-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Stifel Nicolaus Cuts AbCellera Biologics (NASDAQ:ABCL) Price Target to $10.00
AbCellera Biologics (NASDAQ:ABCL – Free Report) had its target price reduced by Stifel Nicolaus from $12.00 to $10.00 in a report published on Friday,Benzinga reports. Stifel Nicolaus currently has a buy rating on the stock. A number of other analysts also recently commented on the stock. KeyCorp decreased their price objective on shares of AbCellera […]
AbCellera Biologics (NASDAQ:ABCL – Free Report) had its target price reduced by Stifel Nicolaus from $12.00 to $10.00 in a report published on Friday,Benzinga reports. Stifel Nicolaus currently has a buy rating on the stock. A number of other analysts also recently commented on the stock. KeyCorp decreased their price objective on shares of AbCellera […]
